Ultragenyx Pharmaceutical Balance Sheet (2015-2025) | RARE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	383.79M	290.88M	197.54M	307.58M	153.99M	159.87M	391.65M	132.94M	85.77M	102.06M	72.58M	214.00M	112.25M	480.69M	150.62M	174.00M	127.06M	176.31M	202.51M	421.00M
Short-term Investments (Quarter)	581.61M	554.88M	539.58M	432.61M	444.33M	382.93M	497.02M	614.82M	543.59M	449.92M	369.52M	363.62M	299.83M	283.13M	470.99M	436.00M	367.38M	311.28M	222.74M	259.00M
Cash & Current Investments (Quarter)	965.41M	845.76M	737.12M	740.20M	598.32M	542.79M	888.67M	747.76M	629.35M	551.98M	442.09M	577.62M	412.08M	763.82M	621.61M	610.00M	494.44M	487.58M	425.25M	680.00M
Receivables - Net (Quarter)	25.03M	14.70M	25.38M	28.43M	17.40M	37.21M	15.20M	27.50M	17.40M	44.80M	54.10M	39.20M	100.25M	67.20M	55.90M	122.00M	1.60M	124.46M	1.70M	1.00M
Receivables - Other (Quarter)	5.10M	3.80M	7.80M	16.00M	3.80M	2.90M	3.20M	6.40M	12.70M	2.30M	0.40M	1.10M	0.20M	2.40M	1.80M	2.00M	2.40M	0.90M	2.10M	1.00M
Receivables (Quarter)	30.13M	18.50M	33.18M	44.43M	21.20M	40.11M	18.40M	33.90M	30.10M	47.10M	54.50M	40.30M	100.45M	69.60M	57.70M	124.00M	4.00M	125.36M	3.80M	2.00M
Work In Process (Quarter)	6.78M	9.46M	9.55M	10.50M	11.99M	16.19M	15.78M	17.49M	15.09M	18.54M	19.17M	18.86M	22.82M	25.25M	20.28M	22.00M	22.91M	19.75M	29.19M	27.00M
Finished Goods (Quarter)	5.68M	5.63M	5.64M	5.73M	5.82M	4.89M	6.07M	9.28M	11.53M	9.72M	12.63M	15.11M	13.09M	14.88M	23.05M	23.00M	23.12M	26.74M	23.01M	25.00M
Inventory (Quarter)	12.46M	15.08M	15.19M	16.23M	17.81M	21.08M	21.85M	26.77M	26.62M	28.26M	31.80M	33.97M	35.91M	40.14M	43.33M	45.00M	46.03M	46.50M	52.20M	52.00M
Prepaid Assets (Quarter)	68.03M	63.93M	69.19M	71.75M	63.02M	77.46M	70.98M	68.93M	67.38M	51.38M	46.03M	47.62M	47.73M	54.70M	41.37M	40.00M	59.84M	61.24M	53.22M	61.00M
Current Assets (Quarter)	1,070.94M	949.49M	846.88M	856.60M	707.52M	678.54M	1,012.67M	883.90M	766.34M	702.14M	599.19M	732.18M	595.97M	964.64M	799.61M	817.00M	699.15M	719.79M	643.21M	951.00M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	87.57M	104.57M	119.07M	141.25M	177.07M	207.38M	234.61M	259.73M	277.87M	288.99M	296.81M	290.57M	285.11M	278.71M	272.45M	266.00M	260.91M	255.76M	249.96M	244.00M
Long-Term Investments (Quarter)	81.62M	128.03M	204.24M	18.50M	215.53M	163.30M	107.56M	2.81M	85.21M	66.37M	82.07M	3.20M	156.58M	110.67M	203.09M	135.00M	68.56M	51.45M	22.07M	57.00M
Goodwill (Quarter)	44.41M	44.41M	44.41M	44.41M	44.41M	44.41M	44.41M	44.41M	44.41M	44.41M	44.41M	44.41M	44.41M	44.41M	44.41M	44.00M	44.41M	44.41M	44.41M	44.00M
Intangibles (Quarter)	131.03M	130.95M	130.87M	131.28M	159.99M	159.20M	158.40M	163.78M	159.17M	158.24M	157.30M	173.78M	165.04M	166.24M	164.94M	178.00M	176.52M	174.73M	172.94M	176.00M
Goodwill & Intangibles (Quarter)	175.44M	175.36M	175.28M	175.68M	204.40M	203.60M	202.81M	208.18M	203.58M	202.64M	201.71M	218.18M	209.45M	210.65M	209.35M	222.00M	220.93M	219.14M	217.35M	220.00M
Other Non-Current Assets (Quarter)	8.93M	12.67M	16.42M	20.56M	21.22M	21.14M	18.29M	48.34M	22.26M	26.49M	27.90M	57.69M	59.97M	53.77M	53.87M	63.00M	62.37M	60.12M	57.86M	60.00M
Non-Current Assets (Quarter)	526.83M	562.95M	637.92M	665.79M	676.51M	642.09M	605.81M	661.54M	617.07M	609.17M	638.95M	758.83M	711.11M	653.80M	738.75M	686.00M	612.77M	586.48M	547.24M	581.00M
Assets (Quarter)	1,597.76M	1,512.44M	1,484.80M	1,522.40M	1,384.03M	1,320.63M	1,618.47M	1,545.44M	1,383.40M	1,311.31M	1,238.14M	1,491.01M	1,307.08M	1,618.44M	1,538.36M	1,503.00M	1,311.93M	1,306.27M	1,190.44M	1,532.00M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	15.74M	21.79M	15.57M	17.14M	23.68M	34.21M	23.53M	43.27M	58.98M	42.12M	33.36M	42.11M	40.97M	59.81M	35.99M	39.00M	47.45M	34.24M	40.57M	31.00M
Payables (Quarter)	15.74M	21.79M	15.57M	17.14M	23.68M	34.21M	23.53M	43.27M	58.98M	42.12M	33.36M	42.11M	40.97M	59.81M	35.99M	39.00M	47.45M	34.24M	40.57M	31.00M
Accumulated Expenses (Quarter)	82.70M	41.55M	109.66M	145.56M	41.64M	170.35M	67.20M	78.94M	144.40M	61.35M	76.30M	82.94M	149.13M	61.05M	82.92M	241.00M	173.01M	61.06M	220.53M	265.00M
Other Accumulated Expenses (Quarter)	25.39M	26.96M	32.24M	42.08M	44.63M	54.70M	59.93M	52.18M	45.88M	51.86M	50.80M		50.21M	29.07M	29.42M	4.00M	3.35M	2.58M	18.95M	24.00M
Current Leases (Quarter)	9.38M	10.30M	10.70M	11.07M	11.32M	11.63M	11.82M	11.78M	11.26M	10.88M	12.07M	12.60M	12.78M	11.72M	10.42M	10.00M	10.49M	11.77M	12.14M	12.00M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	127.04M	127.07M	135.93M	181.37M	167.23M	220.64M	227.36M	261.21M	218.18M	244.38M	253.98M	280.44M	245.57M	272.87M	285.01M	344.00M	291.67M	293.24M	340.02M	384.00M
Non-Current Liabilities
Capital Leases (Quarter)
Minority Interest (Quarter)															7.00M	7.00M	7.00M	7.00M	7.00M	7.00M
Non-Current Deferred Tax Liability (Quarter)	33.31M	33.31M	33.31M	33.31M	33.31M	33.31M	33.31M	31.67M	31.67M	31.67M	31.67M	30.06M	30.06M	30.06M	30.06M	30.00M	30.06M	30.06M	30.06M	30.00M
Operating Leases (Quarter)	36.75M	35.86M	33.34M	30.90M	28.04M	25.90M	22.86M	19.81M	17.34M	14.85M	34.55M	30.57M	27.98M	25.74M	23.66M	30.00M	27.79M	24.53M	21.69M	24.00M
Other Non-Current Liabilities (Quarter)	340.21M	344.04M	348.07M	1.00M	355.63M	3.77M	4.05M	4.82M	886.48M	10.39M	876.00M	862.33M	848.73M	15.20M	16.13M	17.00M	794.05M	17.40M	18.78M	1,147.00M
Total Non-Current Liabilities (Quarter)	202.97M	196.23M	203.05M	598.83M	231.97M	638.79M	1,145.60M	1,188.13M	276.44M	1,171.89M	330.43M	353.27M	318.09M	1,170.82M	1,168.41M	1,224.00M	366.63M	1,130.58M	1,155.51M	458.00M
Total Liabilities (Quarter)	543.18M	540.27M	551.13M	599.84M	587.61M	642.55M	1,149.64M	1,192.95M	1,162.92M	1,182.28M	1,206.43M	1,215.60M	1,166.82M	1,186.02M	1,184.54M	1,241.00M	1,160.68M	1,147.98M	1,174.29M	1,605.00M
Shareholder's Equity
Common Equity (Quarter)	1,054.58M	972.17M	933.67M	922.56M	796.42M	678.07M	468.83M	352.00M	220.48M	129.03M	31.71M	275.00M	140.26M	432.42M	346.83M	255.00M	144.25M	151.29M	9.16M	-80.00M
Shareholder's Equity (Quarter)	1,054.58M	972.17M	933.67M	922.56M	796.42M	678.07M	468.83M	352.00M	220.48M	129.03M	31.71M	275.00M	140.26M	432.42M	346.83M	255.00M	144.25M	151.29M	9.16M	-80.00M
Liabilities and Shareholders Equity (Quarter)	1,597.76M	1,512.44M	1,484.80M	1,522.40M	1,384.03M	1,320.63M	1,618.47M	1,545.44M	1,383.40M	1,311.31M	1,238.14M	1,491.01M	1,307.08M	1,618.44M	1,538.36M	1,503.00M	1,311.93M	1,306.27M	1,190.44M	1,532.00M
Treasury Shares (Quarter)				1.67M				2.13M	0.01M	0.01M	0.01M	1.38M	0.06M	0.07M	0.07M	0.10M	0.16M	0.17M	0.17M	0.80M
Retained Earnings (Quarter)	0.06M	0.23M	0.05M	-1.40M	-6.55M	-2384.08M	-10.22M	-6.57M	-2944.99M	-3104.82M	-2.24M	-3387.66M	-0.43M	-1.09M	-3823.46M	-1.00M	-4107.92M	-0.27M	0.82M	1.00M

Research Tools

Ultragenyx Pharmaceutical Balance Sheet (2015-2025) | RARE

Create an account

Sign In

Reset Password